Cargando…

Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort

INTRODUCTION: Influenza A(H3N2) clades 3C.2a and 3C.3a co-circulated in Europe in 2018/19. Immunological imprinting by first childhood influenza infection may induce future birth cohort differences in vaccine effectiveness (VE). AIM: The I-MOVE multicentre primary care test-negative study assessed 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kissling, Esther, Pozo, Francisco, Buda, Silke, Vilcu, Ana-Maria, Gherasim, Alin, Brytting, Mia, Domegan, Lisa, Gómez, Verónica, Meijer, Adam, Lazar, Mihaela, Vučina, Vesna Višekruna, Dürrwald, Ralf, van der Werf, Sylvie, Larrauri, Amparo, Enkirch, Theresa, O’Donnell, Joan, Guiomar, Raquel, Hooiveld, Mariëtte, Petrović, Goranka, Stoian, Elena, Penttinen, Pasi, Valenciano, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891946/ https://www.ncbi.nlm.nih.gov/pubmed/31796152 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.48.1900604

Ejemplares similares

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
por: Kissling, Esther, et al.
Publicado: (2019)

2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children
por: Kissling, Esther, et al.
Publicado: (2018)

Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons
por: Machado, Ausenda, et al.
Publicado: (2019)

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
por: Kissling, Esther, et al.
Publicado: (2022)

Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020
por: Kissling, Esther, et al.
Publicado: (2021)

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018)

Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I‐MOVE multicentre test‐negative case‐control study, 2011/2012‐2016/2017
por: Valenciano, Marta, et al.
Publicado: (2018)

2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
por: Rondy, Marc, et al.
Publicado: (2017)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16
por: Mazagatos, Clara, et al.
Publicado: (2018)

Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
por: Gherasim, Alin, et al.
Publicado: (2017)

Illness Severity in Hospitalized Influenza Patients by Virus Type and Subtype, Spain, 2010–2017
por: Delgado-Sanz, Concepción, et al.
Publicado: (2020)

Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned
por: Bagaria, Jayshree, et al.
Publicado: (2022)

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis
por: Sandmann, Frank G., et al.
Publicado: (2022)

Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009–2017
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020
por: Rose, Angela, et al.
Publicado: (2020)

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine
por: Rose, Angela M. C., et al.
Publicado: (2020)

Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019
por: Wiman, Åsa, et al.
Publicado: (2019)

Measles outbreak in Dubrovnik-Neretva County, Croatia, May to June 2018
por: Tomljenovic, Morana, et al.
Publicado: (2020)

ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation
por: Penttinen, Pasi, et al.
Publicado: (2016)

Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016
por: Adlhoch, Cornelia, et al.
Publicado: (2017)

Incidence, Severity and Impact of Influenza: a joint meeting organised by the ISIRV Epidemiology Group and ECDC, Stockholm, 2019
por: Rath, Barbara, et al.
Publicado: (2019)

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Author’s reply: Regarding the editorial by Penttinen and Friede
por: Penttinen, Pasi M, et al.
Publicado: (2016)

Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?
por: Penttinen, Pasi M, et al.
Publicado: (2016)

Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
por: Valenciano, Marta, et al.
Publicado: (2011)

64
por: Nuncio, Abraham, 1941-
Publicado: (2011)

Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020
por: Vaughan, Aisling, et al.
Publicado: (2023)

Healthy elderly and influenza vaccination
por: Heins, Marianne J., et al.
Publicado: (2018)

The S-LINK 64 bit extension specification: S-LINK 64
por: Rácz, A, et al.
Publicado: (2003)

Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Listeriosis in Spain based on hospitalisation records, 1997 to 2015: need for greater awareness
por: Herrador, Zaida, et al.
Publicado: (2019)

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
por: Kissling, Esther, et al.
Publicado: (2021)

Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region
por: Adlhoch, Cornelia, et al.
Publicado: (2021)

Occurrence of invasive pneumococcal disease and number of excess cases due to influenza
por: Grabowska, Katarzyna, et al.
Publicado: (2006)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

64 STRAW Prototype
por: Danielsson, H
Publicado: (2010)

The NA64 experiment
por: Brice, Maximilien
Publicado: (2016)

Management Meeting No. 64
por: Reich, K H
Publicado: (1961)

T64. Submission Withdrawn
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_41ftgrb0qoepajh5mfqc7h7o83